Tori Fort

Bio:

Tori is a senior biotechnology executive with more than 20 years of experience guiding companies through pivotal moments of growth, financing, and strategic transformation.

She currently serves as SVP, Corporate Strategy and Corporate Affairs at Ovid Therapeutics, where she partners closely with the leadership team to shape enterprise strategy, investor positioning, and corporate communications. She leads investor relations, including guiding the company through a recent financing that successfully recapitalized the organization, strengthened its balance sheet, and positioned Ovid for its next phase of value creation.

Previously, Tori served as SVP, Strategy and Corporate Affairs at Frontier Medicines, where she helped transition the company to a clinical-stage organization and led investor relations and corporate strategy through an oversubscribed Series C financing.

Prior to joining Frontier, Tori founded and led uncapped, a biotech consultancy within GCI Health Group and WPP, advising emerging and established biopharmaceutical companies including Nkarta, Apellis, Dynavax, and Exscientia on corporate positioning, investor strategy, and growth. She also served as Executive Vice President at GCI Health, counseling global biopharmaceutical leaders.

Across her career, Tori has partnered with executive teams and Boards to launch precision medicines, raise capital, build durable brands, and navigate complex corporate inflection points. She is a recipient of MM&M’s inaugural 40 Under 40 award and holds a bachelor’s degree in economics from Smith College.